11109 related articles for article (PubMed ID: 15782558)
1. Microphthalmia transcription factor: a specific marker for malignant melanoma.
Vachtenheim J; Borovanský J
Prague Med Rep; 2004; 105(3):318-24. PubMed ID: 15782558
[TBL] [Abstract][Full Text] [Related]
2. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis.
King R; Weilbaecher KN; McGill G; Cooley E; Mihm M; Fisher DE
Am J Pathol; 1999 Sep; 155(3):731-8. PubMed ID: 10487831
[TBL] [Abstract][Full Text] [Related]
3. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
Selzer E; Wacheck V; Lucas T; Heere-Ress E; Wu M; Weilbaecher KN; Schlegel W; Valent P; Wrba F; Pehamberger H; Fisher D; Jansen B
Cancer Res; 2002 Apr; 62(7):2098-103. PubMed ID: 11929831
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
[TBL] [Abstract][Full Text] [Related]
5. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms.
O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL
J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840
[TBL] [Abstract][Full Text] [Related]
6. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
7. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
[TBL] [Abstract][Full Text] [Related]
8. Novel MITF targets identified using a two-step DNA microarray strategy.
Hoek KS; Schlegel NC; Eichhoff OM; Widmer DS; Praetorius C; Einarsson SO; Valgeirsdottir S; Bergsteinsdottir K; Schepsky A; Dummer R; Steingrimsson E
Pigment Cell Melanoma Res; 2008 Dec; 21(6):665-76. PubMed ID: 19067971
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical comparison between MiTF and MART-1 with Azure blue counterstaining in the setting of solar lentigo and melanoma in situ.
Hillesheim PB; Slone S; Kelley D; Malone J; Bahrami S
J Cutan Pathol; 2011 Jul; 38(7):565-9. PubMed ID: 21362015
[TBL] [Abstract][Full Text] [Related]
10. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
11. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival.
Widlund HR; Fisher DE
Oncogene; 2003 May; 22(20):3035-41. PubMed ID: 12789278
[TBL] [Abstract][Full Text] [Related]
12. The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis.
Larribere L; Hilmi C; Khaled M; Gaggioli C; Bille K; Auberger P; Ortonne JP; Ballotti R; Bertolotto C
Genes Dev; 2005 Sep; 19(17):1980-5. PubMed ID: 16140982
[TBL] [Abstract][Full Text] [Related]
13. Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
Ugurel S; Houben R; Schrama D; Voigt H; Zapatka M; Schadendorf D; Bröcker EB; Becker JC
Clin Cancer Res; 2007 Nov; 13(21):6344-50. PubMed ID: 17975146
[TBL] [Abstract][Full Text] [Related]
14. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Mod Pathol; 2001 Jan; 14(1):6-9. PubMed ID: 11211309
[TBL] [Abstract][Full Text] [Related]
15. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
[TBL] [Abstract][Full Text] [Related]
16. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
Denat L; Larue L
Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF.
Takeda K; Yokoyama S; Aburatani H; Masuda T; Han F; Yoshizawa M; Yamaki N; Yamamoto H; Eguchi N; Urade Y; Shibahara S
Biochem Biophys Res Commun; 2006 Jan; 339(4):1098-106. PubMed ID: 16337607
[TBL] [Abstract][Full Text] [Related]
18. Microphthalmia-associated transcription factor and tyrosinase as markers of melanoma cells in blood of patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Kusić Z
Croat Med J; 2004 Apr; 45(2):142-8. PubMed ID: 15103749
[TBL] [Abstract][Full Text] [Related]
19. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.
Carreira S; Goodall J; Aksan I; La Rocca SA; Galibert MD; Denat L; Larue L; Goding CR
Nature; 2005 Feb; 433(7027):764-9. PubMed ID: 15716956
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional repression of the microphthalmia gene in melanoma cells correlates with the unresponsiveness of target genes to ectopic microphthalmia-associated transcription factor.
Vachtenheim J; Novotna H; Ghanem G
J Invest Dermatol; 2001 Dec; 117(6):1505-11. PubMed ID: 11886515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
